Last update Dec. 1, 2004

Nelfinavir

High Risk

Poorly safe. Evaluate carefully. Use safer alternative or interrupt breastfeeding 3 to 7 T ½ (elimination half-lives). Read the Comment.

Anti-HIV drug. There is not experience on children younger than 2 years old.

Mothers must be adviced that transmission of HIV infection through breastfeeding has been documented.

Alternatives

We do not have alternatives for Nelfinavir.

Suggestions made at e-lactancia are done by APILAM team, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Group

Nelfinavir belongs to this group or family:

Tradenames

Main tradenames from several countries containing Nelfinavir in its composition:

Pharmacokinetics

Variable Value Unit
Oral Bioavail. 89 %
Molecular weight 568 daltons
Protein Binding 99 %
Tmax 4 hours
T1/2 5 hours

References

  1. CDC - Centers for Disease Control and Prevention, U.S. Department of Health and Human Services. Updated Guidelines for Antiretroviral Postexposure Prophylaxis After Sexual, Injection Drug Use, or Other Nonoccupational Exposure to HIV— United States. nPEP Guidelines Update. 2016 Full text (link to original source) Full text (in our servers)

Total visits

2,091

Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at elactancia.org@gmail.com

e-lactancia is a resource recommended by IHAN of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM